<< Liverpool scientist presents chronic illness study to House of Commons | New surgical glove alleviates need for "double gloving" >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski

New pill for post-traumatic stress disorder

Published on March 22, 2004 at 3:33 AM · No Comments
Every day, people suffer traumatic experiences that scar their minds. Combat, rape, bombings, burns, beatings, and horrific car accidents haunt them with
Wedig, Pitman, Buhlmann
Psychiatrist Roger Pitman checks a simulated test to detect the effects of post-traumatic stress disorder. Ulrike Buhlmann (right), a research fellow, adjusts electrodes on volunteer Michele Wedig which record rapid heartbeats, sweating, muscle twitches, and other signs of stressful memories. (Staff photo Jon Chase/Harvard News Office)
memories impossible to suppress. Such day- and nightmares are part of a problem known as post-traumatic stress disorder, or PTSD.

Psychotherapy - talking it through with a professional - doesn't always bring the peace PTSD sufferers seek. Roger K. Pitman, professor of psychiatry at Harvard Medical School, believes such people can be helped with new drugs that he and others are testing.

"I feel that, sooner or later, we will find a drug that can prevent or substantially reduce PTSD," Pitman says.

He and his colleagues tested a tongue-twister of a drug called propranolol on 41 people who had experienced automobile accidents, assaults, and other traumas serious enough for them to be treated at the emergency room of Massachusetts General Hospital in Boston. The goal was to see if this drug, given within six hours of their mishaps, would prevent terrifying, indelible memories.

Tested three months after an auto accident, one young man, who took a dummy pill as part of the experiment, was still wary about getting into a car. He had nightmares. He sweated, his heart rate jumped, and he felt nervous anytime he got behind the wheel, especially in the area where the accident occurred.

In contrast, others who survived similar accidents and took propranolol had significantly fewer problems.

The most revealing tests were done three months after the traumas, when 22 of the victims returned to Mass General Hospital for evaluation. Eight of these people took propranolol four times a day for 10 days, but had been off the drug for more than two months when tested. Fourteen of the 22 had taken dummy pills, or placebos.

All of them listened to audiotapes on which they had described the incidents that brought them to the emergency room. None of those who took propranolol showed strong responses to the tapes. But eight of the placebo patients were obviously shaken by reliving their traumas. Their heart rates increased, their palms sweated, their muscles twitched - all signs of PTSD.

<<>>

That's a pretty good result. It hints that giving propranolol to soldiers traumatized by combat in Iraq and Afghanistan, to young boys or girls who have been sexually assaulted, to victims of terrorist bombings and rape might be a good idea. But Pitman is a cautious scientist. Before issuing propranolol or any other PTSD drug to military medics, firefighters, police officers, and emergency medical technicians, more testing needs to be done with larger numbers of people.

Why did some of the people who didn't take the drug come out as well as those who did take it? What's the best dosage? What about side effects? To get answers, Pitman and his colleagues have begun a study that will include about 200 people who are treated for trauma in the emergency rooms at Massachusetts General and Brigham and Women's hospitals in Boston. Both hospitals are affiliated with Harvard Medical School.

Pitman's colleagues are testing another drug, paroxetine (Paxil), on burn victims. Paxil has already been approved for treatment of PTSD but not for its prevention. Propranolol is approved for treating hypertension.

Recently, investigators in France reported on experiments showing that propranolol reduces PTSD symptoms. Researchers at the University of California, San Diego, have also been testing propranolol and another drug called guanfacine. They are expected to publish their results soon.

"The object of these drugs is not to make people forget their traumatic experiences," Pitman explains, "but to reduce the intensity of the memories to a more normal level, a level that a person can easily live with."

He sees post-traumatic stress disorder as a perfectly natural process gone amok. Pitman puts it this way: Suppose one of our primitive ancestors, while looking for a good water hole in Africa, is attacked by a crocodile. That person had better remember where the attack took place or he or she stands to be removed from the human gene pool.

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading